OncoTEX Employee Directory
Biotechnology ResearchTexas, United States2-10 Employees
OncoTEX is a biotechnology research company based in Austin, Texas, focused on developing cancer therapies. It is building TEX Core, a platform designed to enable new oncology drugs capable of overcoming key limitations of current treatments, including resistance to platinum-based regimens. OxaliTEX is the first clinical candidate derived from TEX Core, targeted at platinum-resistant ovarian cancer. In October 2021, OncoTEX announced the appointment of Dr. Jonathan F. Arambula as Chief Executive Officer. As a small biotechnology firm concentrated on oncology research, OncoTEX seeks to advance therapies that address resistance to platinum-based standard-of-care treatments.